Search for: "Fields v. Holder et al" Results 61 - 80 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2018, 4:12 am by Simon Holzer
In an obiter dictum, however, the Federal Supreme Court ruled that new SPCs for combination products must comply with the requirements of the Medeva et al. case law of the CJEU in the future. [read post]
12 Mar 2012, 8:13 am by Ronald Collins
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
30 Jul 2018, 10:44 am by Lisa Ouellette
(Builds on scholars such as Sean Seymore and Ben Roin; see also Krieger et al. on drug novelty. [read post]
27 Sep 2019, 6:00 am by Rebecca Tushnet
Q: rate of innovation v. direction of innovation—are we even capable of directional? [read post]
26 Dec 2016, 4:30 am by Ben
Well Marie-Andree cited that 1879 case  Feist Publications, Inc. v. [read post]
31 Jan 2011, 9:12 pm
Easton Enterprises et al (CAFC 2010-1057, -1116) precedential Tokai didn't get evidence in because of procedural error: failure to submit written reports for its experts, Jones and Sung. [read post]
24 Oct 2010, 7:02 am
Had Google gotten their way, Viacom would have had to join forces with Premier League et al to file one appeal brief. [read post]
30 Dec 2018, 3:03 am by Ben
Court of Appeals, Ninth Circuit in Folkens v Wyland. [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]